Meet our Team of Innovators
Tyler-Davis Ogden
CEO
Tyler Ogden is a visionary healthcare entrepreneur and member of the Harvard Medical School Global Health Leaders Program. He started a pioneering company in the amniotic allograft space. With a decade of experience, Tyler has led groundbreaking advancements in healthcare, wound healing, tissue repair & diabetes. His innovative approach and unwavering commitment to improving patient outcomes have positioned GHI for greatness. Tyler's passion for cuttingedge biotechnologies, drives the company's mission to transform healthcare through the power of regenerative solutions and cutting edge treatment protocols. Under his leadership, GHI continues to set new standards in medical innovation.
Antonio Swad
Executive Chairman
Antonio Swad is the executive chairman for GHI and a renowned American entrepreneur celebrated for his visionary impact on the food and beverage industry. As the founder of highly successful restaurant chains like Wingstop and Pizza Patron, Swad has demonstrated a remarkable ability to identify untapped market opportunities and deliver innovative dining experiences. His expertise in market trends, branding, and commitment to quality has been instrumental in transforming his ventures into globally recognized brands. Swad’s entrepreneurial acumen and creative vision have not only fueled the growth of his companies but also solidified his reputation as a leader in the industry. With an unwavering focus on fulfilling niche demands, his work continues to inspire aspiring entrepreneurs and shape the future of dining worldwide. From local beginnings to international success, Swad’s journey exemplifies the power of determination, ingenuity, and an enduring passion for excellence.
Michael Goeree
Partner
Micheal is a originally from the Netherlands and is a Special Forces veteran of The Royal Netherlands Army. Micheal is the CEO of Medfiniti. Medfiniti operaties Hemwell MD. “We are specialists in medical technology, medical and surgical clinics, medical business strategy and medical mergers and acquisitions. We maintain a single focus through coordinated mergers, acquisitions along with a combined growth strategy, divestitures and licensing agreements. As a result of our focused attention to the medical sector globally, we have a pointed understanding of the healthcare industry, the value of clinical efficacy, intellectual property, regulatory approval, insurance program reimbursements and, most importantly, hold and maintain strong industry contacts and relationships.”